These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 29747032

  • 1. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I, Melkemi N, Salah T, Ghalem S.
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [Abstract] [Full Text] [Related]

  • 2. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA, Shah MS, Saeed A, Shah HS, Channar PA, Bolte M, Iqbal J.
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [Abstract] [Full Text] [Related]

  • 5. Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group.
    Liu H, Liu L, Gao X, Liu Y, Xu W, He W, Jiang H, Tang J, Fan H, Xia X.
    Eur J Med Chem; 2017 Jan 27; 126():810-822. PubMed ID: 27951489
    [Abstract] [Full Text] [Related]

  • 6. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V, Saha A, Roy K.
    Comput Biol Chem; 2020 Oct 27; 88():107355. PubMed ID: 32801088
    [Abstract] [Full Text] [Related]

  • 7. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
    Saeedi M, Felegari P, Iraji A, Hariri R, Rastegari A, Mirfazli SS, Edraki N, Firuzi O, Mahdavi M, Akbarzadeh T.
    Arch Pharm (Weinheim); 2021 Mar 27; 354(3):e2000258. PubMed ID: 33226157
    [Abstract] [Full Text] [Related]

  • 8. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V, De P, Ojha PK, Saha A, Roy K.
    Curr Top Med Chem; 2020 Mar 27; 20(18):1601-1627. PubMed ID: 32543359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM, Feng B, Fu H, Liu AL, Wang L, Du GH, Wu S.
    Molecules; 2017 Jan 20; 22(1):. PubMed ID: 28117700
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Jan 20; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
    Cavdar H, Senturk M, Guney M, Durdagi S, Kayik G, Supuran CT, Ekinci D.
    J Enzyme Inhib Med Chem; 2019 Dec 20; 34(1):429-437. PubMed ID: 30734597
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M, Khoobi M, Nadri H, Sakhteman A, Moradi A, Ghandi M, Foroumadi A, Shafiee A.
    Arch Pharm (Weinheim); 2013 Aug 20; 346(8):577-87. PubMed ID: 23852709
    [Abstract] [Full Text] [Related]

  • 18. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS, Khan MI, Alharbi AH, Ahmad V, Yadav BS.
    Nutrients; 2023 Mar 24; 15(7):. PubMed ID: 37049419
    [Abstract] [Full Text] [Related]

  • 19. A Series of Novel 1-H-isoindole-1,3(2H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies.
    Krzyżak E, Marciniak A, Szkatuła D, Jankowska KA, Dobies N, Kotynia A.
    Molecules; 2024 Jul 26; 29(15):. PubMed ID: 39124935
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R, Pourshojaei Y, Eskandari K, Mohammadi-Khanaposhtani M, Abiri A, Khodadadi A, Langarizadeh A, Sharififar F, Amirheidari B, Akbarzadeh T, Lotfian H, Foroumadi A, Asadipour A.
    Arch Pharm (Weinheim); 2019 Jul 26; 352(7):e1800352. PubMed ID: 31136018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.